https://robertgish.com/404 2026-03-29 daily 0.5 https://robertgish.com/aasld-2018-meeting 2026-03-29 daily 0.5 https://robertgish.com/about 2026-03-29 daily 0.5 https://robertgish.com/appeal-templates 2026-03-29 daily 0.5 https://robertgish.com/community-ngo 2026-03-29 daily 0.5 https://robertgish.com/consulting-industry 2026-03-29 daily 0.5 https://robertgish.com/consulting-scope 2026-03-29 daily 0.5 https://robertgish.com/contact-success 2026-03-29 daily 0.5 https://robertgish.com/contact 2026-03-29 daily 0.5 https://robertgish.com/assets/custom.css 2026-03-29 daily 0.5 https://robertgish.com/giving 2026-03-29 daily 0.5 https://robertgish.com/hcv-report 2026-03-29 daily 0.5 https://robertgish.com/ 2026-03-29 daily 0.5 https://robertgish.com/mini-lectures 2026-03-29 daily 0.5 https://robertgish.com/patients-caregivers 2026-03-29 daily 0.5 https://robertgish.com/podcast 2026-03-29 daily 0.5 https://robertgish.com/policy 2026-03-29 daily 0.5 https://robertgish.com/projects-institutions 2026-03-29 daily 0.5 https://robertgish.com/providers-clinicians 2026-03-29 daily 0.5 https://robertgish.com/resources 2026-03-29 daily 0.5 https://robertgish.com/robots.txt 2026-03-29 daily 0.5 https://robertgish.com/sitemap.xml 2026-03-29 daily 0.5 https://robertgish.com/taf-appeal 2026-03-29 daily 0.5 https://robertgish.com/transparency-ppsa 2026-03-29 daily 0.5 https://robertgish.com/vhep-west-africa 2026-03-29 daily 0.5 https://robertgish.com/webinars 2026-03-29 daily 0.5 https://robertgish.com/blog/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/2/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/3/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/4/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/5/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/6/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/7/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/8/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/9/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/10/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/11/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/12/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/13/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/14/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/15/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/16/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/17/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/18/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/19/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/20/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/21/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/22/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/23/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/24/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/25/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/26/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/27/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/28/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/29/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/30/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/31/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/32/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/33/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/34/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/35/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/36/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/37/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/38/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/39/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/40/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/41/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/42/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/43/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/44/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/45/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/46/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/47/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/48/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/49/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/50/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/51/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/52/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/53/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/54/index 2026-03-29 daily 0.5 https://robertgish.com/blog/page/55/index 2026-03-29 daily 0.5 https://robertgish.com/feed.xml 2026-03-29 daily 0.5 https://robertgish.com/feed.xslt.xml 2026-03-29 daily 0.5 https://robertgish.com/blog/priorities-for-a-chronic-hepatitis-B-functional-cure-treatment-pathway 2026-01-13 daily 0.5 https://robertgish.com/blog/magical-thinking-will-not-prevent-future-pandemics-or-improve-public-health 2026-01-08 daily 0.5 https://robertgish.com/blog/broadening-peth-testing-for-alcohol-exposure-in-the-asia-pacific-region 2025-12-18 daily 0.5 https://robertgish.com/blog/strategies-to-achieve-functional-cure-in-hbv-focus-on-sirna 2025-11-25 daily 0.5 https://robertgish.com/blog/re-removal-of-vemlidy-from-cvs-health-formularies 2025-11-20 daily 0.5 https://robertgish.com/blog/patient-engagement-as-a-habit 2025-11-10 daily 0.5 https://robertgish.com/blog/aasld-idsa-practice-guideline-on-treatment-of-chronic-hepatitis-b 2025-11-04 daily 0.5 https://robertgish.com/blog/best-practices-for-screening-testing-diagnosing-and-treating-patients-with-hepatitis-d 2025-10-09 daily 0.5 https://robertgish.com/blog/broadening-peth-testing-for-alcohol-exposure-in-the-asia-pacific-region 2025-09-29 daily 0.5 https://robertgish.com/blog/service-delivery-models-for-people-living-with-chronic-hepatitis-b 2025-08-27 daily 0.5 https://robertgish.com/blog/Letter-of-Medical-Necessity-for-AFP-L3-and-DCP 2025-07-31 daily 0.5 https://robertgish.com/blog/scientific-and-medical-evidence-informing-expansion-of-hepatitis-b-treatment-guidelines 2025-07-30 daily 0.5 https://robertgish.com/blog/patient-and-public-health-perspectives-to-inform-expansion-of-hepatitis-b-treatment-guidelines 2025-07-29 daily 0.5 https://robertgish.com/blog/duration-of-nucleos-t-ide-analogue-treatments 2025-07-18 daily 0.5 https://robertgish.com/blog/a-call-to-reclassify-the-delta-hepatitis-virus-as-an-orphan-disease 2025-07-17 daily 0.5 https://robertgish.com/blog/standardising-hbv-nomenclature-a-call-to-action-from-the-hbv-forum 2025-06-05 daily 0.5 https://robertgish.com/blog/first-u-s-nationwide-seroprevalence-study-on-hdv-hbv 2025-05-21 daily 0.5 https://robertgish.com/blog/screening-for-liver-disease-the-work-up-and-diagnosis-of-acute-and-chronic-liver-disease-2025 2025-04-25 daily 0.5 https://robertgish.com/blog/a-nationwide-study-of-primary-biliary-cholangitis-prevalence 2025-04-14 daily 0.5 https://robertgish.com/blog/easl-ern-clinical-practice-guidelines-on-wilson-s-disease 2025-04-10 daily 0.5 https://robertgish.com/blog/hbv-the-next-decade-of-discovery 2025-03-22 daily 0.5 https://robertgish.com/blog/new-hepatitis-c-point-of-care-test-and-treat-algorithm 2025-03-21 daily 0.5 https://robertgish.com/blog/hdv-where-do-we-go-with-double-reflex-testing 2025-03-18 daily 0.5 https://robertgish.com/blog/overview-of-the-epidemiology-and-burden-of-hepatitis-a-and-b-and-vaccine-updates 2025-02-25 daily 0.5 https://robertgish.com/blog/the-urgent-need-to-end-hepatitis-b-stigma-and-discrimination 2025-02-14 daily 0.5 https://robertgish.com/blog/aga-clinical-practice-guideline-on-the-prevention-and-treatment-of-hepatitis-b 2025-02-07 daily 0.5 https://robertgish.com/blog/evaluating-the-impact-of-phosphatidylethanol-testing-on-hospital-outcomes 2025-01-14 daily 0.5 https://robertgish.com/blog/the-urgent-need-to-end-hepatitis-b-stigma-and-discrimination 2024-12-29 daily 0.5 https://robertgish.com/blog/a-cancer-causing-virus-hiding-in-millions-of-americans 2024-12-23 daily 0.5 https://robertgish.com/blog/adult-hepatitis-b-hbv-screening-information-for-providers 2024-12-19 daily 0.5 https://robertgish.com/blog/patient-reported-outcomes-in-chronic-hepatitis-delta-an-exploratory-analysis-of-the-phase-iii-myr301-trial-of-bulevirtide 2024-12-17 daily 0.5 https://robertgish.com/blog/costs-associated-with-nonalcoholic-steatohepatitis-disease-progression 2024-11-25 daily 0.5 https://robertgish.com/blog/establishing-baseline-framework-for-hepatitis-b-virus-in-ho-chi-minh-city-vietnam 2024-11-21 daily 0.5 https://robertgish.com/blog/risk-of-incident-extrahepatic-cancers-among-medicare-patients-with-nash 2024-11-19 daily 0.5 https://robertgish.com/blog/progression-from-non-alcoholic-steatohepatitis-to-advanced-liver-diseases 2024-10-09 daily 0.5 https://robertgish.com/blog/statins-liver-facts-and-fiction 2024-08-27 daily 0.5 https://robertgish.com/blog/liver-connect-symposium 2024-08-19 daily 0.5 https://robertgish.com/blog/hdv-101-hepatitis-b-echo 2024-08-16 daily 0.5 https://robertgish.com/blog/use-of-zinc-for-wilson-disease 2024-08-13 daily 0.5 https://robertgish.com/blog/comprehensive-approach-to-controlling-chronic-hepatitis-b-in-china 2024-08-02 daily 0.5 https://robertgish.com/blog/Patient-reported-outcomes-in-chronic-hepatitis-delta 2024-08-01 daily 0.5 https://robertgish.com/blog/development-and-validation-of-a-biomarker-index-for-hcc-treatment-response 2024-07-12 daily 0.5 https://robertgish.com/blog/time-for-a-treat-all-approach-for-hepatitis-b 2024-07-04 daily 0.5 https://robertgish.com/blog/treat-all-strategy-for-patients-with-chronic-hepatitis-b-virus-infection-in-china 2024-05-30 daily 0.5 https://robertgish.com/blog/community-involvement-in-new-who-hepatitis-b-guidelines 2024-05-23 daily 0.5 https://robertgish.com/blog/resources-and-articles-on-coagulation 2024-05-03 daily 0.5 https://robertgish.com/blog/hepatitis-b-reactivation-risk-on-immunosuppressants-with-a-focus-on-newer-immunomodulators 2024-04-29 daily 0.5 https://robertgish.com/blog/researchers-call-flexible-editorial-conduct-with-the-new-masld-nomenclature 2024-04-18 daily 0.5 https://robertgish.com/blog/hepatocellular-carcinoma-hcc-treatment-algorithm 2024-04-16 daily 0.5 https://robertgish.com/blog/estimating-the-prevalence-of-hepatitis-delta-virus-infection-among-adults-in-the-us 2024-04-08 daily 0.5 https://robertgish.com/blog/what-is-the-current-status-of-hepatitis-b-virus-viro-immunology 2024-04-02 daily 0.5 https://robertgish.com/blog/experience-and-impact-of-stigma-in-people-with-chronic-hepatitis-b 2024-02-28 daily 0.5 https://robertgish.com/blog/AFP-L3-and-DCP-strongly-predict-early-hepatocellular-carcinoma-recurrence 2024-02-21 daily 0.5 https://robertgish.com/blog/researchers-call-for-more-flexible-editorial-conduct 2024-02-12 daily 0.5 https://robertgish.com/blog/urgent-need-for-lived-experience-in-hepatitis-b-guideline-development 2024-02-06 daily 0.5 https://robertgish.com/blog/hep-free-hawai-i-brochures 2024-01-09 daily 0.5 https://robertgish.com/blog/the-importance-of-triple-panel-testing-for-hepatitis-b 2023-12-18 daily 0.5 https://robertgish.com/blog/advances-in-viral-hepatitis-b-and-d-moving-toward-the-goals-of-elimination 2023-11-22 daily 0.5 https://robertgish.com/blog/hepatitis-delta-virus-infection-in-patients-with-hepatitis-b-in-the-united-states 2023-11-18 daily 0.5 https://robertgish.com/blog/the-epidemiology-of-hepatitis-b-virus 2023-10-31 daily 0.5 https://robertgish.com/blog/disease-progression-among-commercially-insured-hdv-infected-patients-in-the-us 2023-10-20 daily 0.5 https://robertgish.com/blog/2023-update-of-inasl-consensus-on-management-of-intermediate-and-advanced-hcc 2023-10-09 daily 0.5 https://robertgish.com/blog/barriers-to-hbv-care 2023-10-06 daily 0.5 https://robertgish.com/blog/increasing-awareness-and-treatment-competencies-for-practicing-clinicians 2023-10-05 daily 0.5 https://robertgish.com/blog/global-prevalence-of-hepatitis-b-in-2022-a-modelling-study 2023-09-20 daily 0.5 https://robertgish.com/blog/on-treatment-risks-of-cirrhosis-and-hepatocellular-carcinoma 2023-09-06 daily 0.5 https://robertgish.com/blog/pathway-to-global-elimination-of-hepatitis-b-hbv-cure-is-just-the-first-step 2023-09-01 daily 0.5 https://robertgish.com/blog/guidelines-for-the-prevention-and-treatment-of-chronic-hepatitis-b 2023-08-17 daily 0.5 https://robertgish.com/blog/hbv-vaccine-faqs 2023-08-02 daily 0.5 https://robertgish.com/blog/diagnosis-and-management-of-hepatitis-delta-virus-infection 2023-07-26 daily 0.5 https://robertgish.com/blog/the-rule-of-5-s-reasons-to-treat-hbv-5-pillars 2023-05-10 daily 0.5 https://robertgish.com/blog/genotype-documentation-fact-sheet 2023-04-19 daily 0.5 https://robertgish.com/blog/updated-assessment-of-chronic-hepatitis-b 2023-04-10 daily 0.5 https://robertgish.com/blog/diagnostic-report-templates 2023-04-06 daily 0.5 https://robertgish.com/blog/how-federally-qualified-health-centers-can-improve-patient-access-to-treatment 2023-03-31 daily 0.5 https://robertgish.com/blog/diagnosing-and-screening-for-hepatitis-d-viral-infection 2023-03-01 daily 0.5 https://robertgish.com/blog/future-of-chronic-hepatitis-b-infection-therapies 2023-02-22 daily 0.5 https://robertgish.com/blog/low-performance-of-hepatitis-delta-virus-testing 2023-01-17 daily 0.5 https://robertgish.com/blog/aspins-potential-agents-for-chronic-hbv-cure-regimens 2022-11-28 daily 0.5 https://robertgish.com/blog/bulevirtide-improves-health-related-quality-of-life 2022-11-11 daily 0.5 https://robertgish.com/blog/measuring-iron-in-the-liver 2022-10-26 daily 0.5 https://robertgish.com/blog/economic-burden-and-hepatitis-d-infection 2022-10-16 daily 0.5 https://robertgish.com/blog/international-liver-cancer-movement-ilcm-fact-sheet 2022-09-09 daily 0.5 https://robertgish.com/blog/hcv-daa-treatment-appeal-letters-updated 2022-05-19 daily 0.5 https://robertgish.com/blog/screening-for-liver-disease-2022 2022-05-02 daily 0.5 https://robertgish.com/blog/global-incidence-and-mortality-of-hepatitis-b-and-hepatitis-c-acute-infections 2022-04-13 daily 0.5 https://robertgish.com/blog/quantitative-magnetic-resonance-imaging-to-aid-clinical-decision-making-in-autoimmune-hepatitis 2022-03-26 daily 0.5 https://robertgish.com/blog/recognizing-hepatitis-d-hdv 2022-03-14 daily 0.5 https://robertgish.com/blog/a-multi-analyte-cell-free-dnabased-blood-test-for-early-detection-of-hepatocellular-carcinoma 2022-03-04 daily 0.5 https://robertgish.com/blog/universal-screening-for-hepatitis-delta 2022-02-28 daily 0.5 https://robertgish.com/blog/cutting-down-medi-cal-managed-care-plans-is-big-mistake 2022-02-24 daily 0.5 https://robertgish.com/blog/importance-of-universal-screening-for-chronic-hepatitis-b-infection-in-adults-in-the-united-states 2022-01-06 daily 0.5 https://robertgish.com/blog/progressive-scale-up-of-hbv-and-hcv-testing-for-hepatitis-elimination-in-vietnam 2021-12-28 daily 0.5 https://robertgish.com/blog/hepatitis-c-vaccination-wherewe-are-andwherewe-need-to-be 2021-12-15 daily 0.5 https://robertgish.com/blog/prevention-and-management-of-viral-hepatitis-in-healthcare-workers-in-ho-chi-minh-city-vietnam 2021-10-22 daily 0.5 https://robertgish.com/blog/cure-everyone-and-vaccinate-the-rest-the-patient-perspective-on-future-hepatitis-b-treatment 2021-08-11 daily 0.5 https://robertgish.com/blog/mafld-and-cardiovascular-events-what-does-the-evidence-show 2021-08-02 daily 0.5 https://robertgish.com/blog/what-is-hepatitis-delta 2021-07-30 daily 0.5 https://robertgish.com/blog/guidelines-on-nits-for-evaluation-of-liver-disease-severity-and-prognosis 2021-07-08 daily 0.5 https://robertgish.com/blog/one-time-universal-screening-for-hepatitis-b-could-save-23k-lives-nearly-600-million 2021-05-14 daily 0.5 https://robertgish.com/blog/chronic-hepatitis-b-prevalence-among-foreign-born-persons-living-in-the-united-states 2021-05-12 daily 0.5 https://robertgish.com/blog/rare-disease-database-hepatitis-b 2021-05-03 daily 0.5 https://robertgish.com/blog/hepatitis-b-update-2021 2021-04-18 daily 0.5 https://robertgish.com/blog/the-pruritus-sheet 2021-03-29 daily 0.5 https://robertgish.com/blog/assessment-of-treatment-options-for-patients-with-hepatitis-c-virus-recombinant-form-2k1b 2021-02-15 daily 0.5 https://robertgish.com/blog/dr-gish-clinic-locations 2021-02-07 daily 0.5 https://robertgish.com/blog/know-your-a-b-cs-a-viral-hepatitis-initiative-for-all-adults-in-the-u-s 2021-01-29 daily 0.5 https://robertgish.com/blog/hepatitis-a-outbreak-during-the-covid-19-pandemic 2021-01-14 daily 0.5 https://robertgish.com/blog/normal-alkaline-phosphatase-levels-are-dependent-on-raceethnicity 2021-01-07 daily 0.5 https://robertgish.com/blog/point-of-care-examinations-for-liver-disease-improved-outcomes 2021-01-04 daily 0.5 https://robertgish.com/blog/needs-of-individuals-living-with-hepatitis-delta-virus-and-their-caregivers-20162019 2020-12-21 daily 0.5 https://robertgish.com/blog/living-with-silent-liver-disease-podcast 2020-12-18 daily 0.5 https://robertgish.com/blog/assessment-of-treatment-options-for-patients-with-hepatitis-c-virus-recombinant-form-2k1b 2020-12-10 daily 0.5 https://robertgish.com/blog/nafld-and-dietary-patterns 2020-12-03 daily 0.5 https://robertgish.com/blog/chronic-hepatitis-b-virus-with-increased-hepatitis-b-virus-dna-and-normal-alanine-aminotransferase 2020-11-27 daily 0.5 https://robertgish.com/blog/screening-for-nonalcoholic-fatty-liver-disease-in-the-primary-care-clinic 2020-11-23 daily 0.5 https://robertgish.com/blog/assessing-the-cost-utility-of-preferentially-administering-heplisav-b-vaccine 2020-11-17 daily 0.5 https://robertgish.com/blog/hepatitis-b-virus-diagnostics-anything-new 2020-11-14 daily 0.5 https://robertgish.com/blog/division-of-viral-hepatitis-strategic-plan-2025 2020-11-10 daily 0.5 https://robertgish.com/blog/viral-hepatitis-best-of-digital-ilc 2020-10-29 daily 0.5 https://robertgish.com/blog/benign-liver-tumors 2020-10-20 daily 0.5 https://robertgish.com/blog/coronavirus-covid-19-and-pbc-revised 2020-10-16 daily 0.5 https://robertgish.com/blog/we-are-all-africans-a-highly-personal-migratory-view-of-the-history-of-hepatitis-b 2020-10-08 daily 0.5 https://robertgish.com/blog/hepatitis-b-awareness-toolkit 2020-10-04 daily 0.5 https://robertgish.com/blog/hepatitis-b-core-antibody-role-in-clinical-practice-in-2020 2020-09-29 daily 0.5 https://robertgish.com/blog/management-of-pbc-2020 2020-09-26 daily 0.5 https://robertgish.com/blog/hepatitis-b-current-data-and-hot-topics 2020-09-22 daily 0.5 https://robertgish.com/blog/early-detection-of-liver-disease-in-community-health-centers 2020-09-17 daily 0.5 https://robertgish.com/blog/hepatocellular-carcinoma-looking-back-from-2020 2020-09-05 daily 0.5 https://robertgish.com/blog/updated-estimate-for-prevalence-of-chronic-hepatitis-b 2020-08-31 daily 0.5 https://robertgish.com/blog/we-need-your-signature-for-hepatitis-c-treatment-access 2020-08-29 daily 0.5 https://robertgish.com/blog/hcc-expert-video-released 2020-08-12 daily 0.5 https://robertgish.com/blog/clinic-locations 2020-08-06 daily 0.5 https://robertgish.com/blog/nutrition-in-health-and-liver-disease 2020-07-31 daily 0.5 https://robertgish.com/blog/hcc-surveillance-in-an-era-of-biomarkers-revised 2020-07-29 daily 0.5 https://robertgish.com/blog/hepatitis-b-core-antibody-role-in-clinical-practice-in-2020 2020-07-21 daily 0.5 https://robertgish.com/blog/practice-changing-updates-on-advanced-and-intermediate-hcc 2020-07-11 daily 0.5 https://robertgish.com/blog/screening-for-liver-disease 2020-07-09 daily 0.5 https://robertgish.com/blog/introduction-to-icu-care-in-cld 2020-06-24 daily 0.5 https://robertgish.com/blog/dr-gish-started-with-loma-linda-university-april-1 2020-06-22 daily 0.5 https://robertgish.com/blog/liver-lady-coloring-books 2020-06-19 daily 0.5 https://robertgish.com/blog/metal-diseases-affecting-the-liver 2020-06-17 daily 0.5 https://robertgish.com/blog/hcv-and-hbv-toolkits 2020-06-13 daily 0.5 https://robertgish.com/blog/moving-from-recommendations-to-reality-bridging-the-hepatitis-b-vaccination-gap 2020-06-10 daily 0.5 https://robertgish.com/blog/alpha-fetoprotein-prognostic-biomarker-in-the-management-of-advanced-hepatocellular 2020-06-09 daily 0.5 https://robertgish.com/blog/twinoxide-and-sars-cov-2-disinfection 2020-06-08 daily 0.5 https://robertgish.com/blog/fda-approves-atezolizumab-plus-bevacizumab-for-frontline-hcc 2020-06-04 daily 0.5 https://robertgish.com/blog/hepatitis-b-update-2020 2020-06-02 daily 0.5 https://robertgish.com/blog/liver-care-and-liver-transplant-outcomes 2020-05-31 daily 0.5 https://robertgish.com/blog/targeted-tyrosine-kinase-inhibitors-and-advanced-hepatocellular-carcinoma 2020-05-29 daily 0.5 https://robertgish.com/blog/identifying-and-managing-hepatitis-b-at-the-primary-care-level-during-covid-19 2020-05-28 daily 0.5 https://robertgish.com/blog/current-and-future-therapies-for-covid19-sars-cov2-updated 2020-05-15 daily 0.5 https://robertgish.com/blog/rna-interference-therapy-with-arc-520-results 2020-04-25 daily 0.5 https://robertgish.com/blog/gastrointestinal-and-liver-manifestations-of-covid-19-updated 2020-04-23 daily 0.5 https://robertgish.com/blog/nits-and-nash-how-to-use-the-complementary-7-overview 2020-04-21 daily 0.5 https://robertgish.com/blog/covid-19-and-hbv-part2 2020-03-25 daily 0.5 https://robertgish.com/blog/medical-student-covid-19-curriculum 2020-03-21 daily 0.5 https://robertgish.com/blog/hbv-elimination-101 2020-03-20 daily 0.5 https://robertgish.com/blog/nash-vs-nafld-what-about-ash-diagnostic-and-treatment-implications 2020-03-18 daily 0.5 https://robertgish.com/blog/nonalcoholic-steatohepatitis 2020-03-16 daily 0.5 https://robertgish.com/blog/coronavirus-why-you-must-act-now 2020-03-15 daily 0.5 https://robertgish.com/blog/study-covid-19-is-also-spread-by-fecal-oral-route 2020-03-14 daily 0.5 https://robertgish.com/blog/covid-19-and-hbv 2020-03-13 daily 0.5 https://robertgish.com/blog/screening-for-hepatitis-c-virus-infection-in-adolescents-and-adults 2020-03-07 daily 0.5 https://robertgish.com/blog/hepatitis-b-educational-resources-for-african-immigrants-in-the-u-s 2020-03-04 daily 0.5 https://robertgish.com/blog/request-for-appeal-of-prior-authorization-denial-gt1-and-gt3 2020-03-02 daily 0.5 https://robertgish.com/blog/hiv-testing 2020-02-28 daily 0.5 https://robertgish.com/blog/obesity-and-hepatitis-adding-insult-to-injury 2020-02-25 daily 0.5 https://robertgish.com/blog/the-11th-asia-pacific-primary-liver-cancer-expert-meeting 2020-02-20 daily 0.5 https://robertgish.com/blog/global-hepatitis-summit-2020-taipei-taiwan 2020-02-15 daily 0.5 https://robertgish.com/blog/obesity-drug-abuse-prevention 2020-02-10 daily 0.5 https://robertgish.com/blog/nash-overview-and-2020-update 2020-02-05 daily 0.5 https://robertgish.com/blog/pbc-foundation-aasld-guidance 2020-01-30 daily 0.5 https://robertgish.com/blog/translations-of-li-rads-v2017-us-and-ceus-core-documents 2020-01-27 daily 0.5 https://robertgish.com/blog/global-hepatitis-summit-2020-taipei 2020-01-09 daily 0.5 https://robertgish.com/blog/metabolic-co-morbidities-and-higher-risk-of-advanced-fibrosis-in-patients-with-nonalcoholic-steatohepatitis 2020-01-06 daily 0.5 https://robertgish.com/blog/nih-strategic-plan-details-pathway-to-achieving-hepatitis-b-cure 2019-12-28 daily 0.5 https://robertgish.com/blog/duckworth-introduces-bill-to-increase-investments-in-liver-cancer-research-raise-awareness 2019-12-24 daily 0.5 https://robertgish.com/blog/thank-you-for-attending-hep-dart-2019 2019-12-21 daily 0.5 https://robertgish.com/blog/happy-holidays-2019 2019-12-18 daily 0.5 https://robertgish.com/blog/facts-and-fiction-in-the-epidemiology-of-chronic-viral-hepatitis 2019-12-15 daily 0.5 https://robertgish.com/blog/update-hepatitis-b-abstracts-from-aasld-2019 2019-12-09 daily 0.5 https://robertgish.com/blog/elevated-alpha-fetoprotein 2019-12-03 daily 0.5 https://robertgish.com/blog/nash-vs-nafld-diagnostic-and-treatment-implications 2019-11-29 daily 0.5 https://robertgish.com/blog/hepatitis-a-b-c-d-e-anything-new 2019-11-26 daily 0.5 https://robertgish.com/blog/combination-of-immunotherapy-and-vegf-inhibitor-improves-survival-in-hepatocellular-carcinoma 2019-11-25 daily 0.5 https://robertgish.com/blog/quick-answers-to-complex-questions-in-hbv 2019-11-23 daily 0.5 https://robertgish.com/blog/dose-response-with-the-rna-interference-therapy 2019-11-19 daily 0.5 https://robertgish.com/blog/call-to-action-for-liver-associations-to-advance-progress-towards-viral-hepatitis-elimination 2019-11-16 daily 0.5 https://robertgish.com/blog/hcc-surveillance-in-an-era-of-biomarkers-application-of-state-of-the-art-tools 2019-11-09 daily 0.5 https://robertgish.com/blog/a-review-of-open-label-renal-and-bone-mineral-density-safety-data 2019-11-02 daily 0.5 https://robertgish.com/blog/activist-guide-to-hepatitis-c-virus-diagnostics 2019-10-31 daily 0.5 https://robertgish.com/blog/evaluation-of-hepatitis-b-and-c-prevalence 2019-10-25 daily 0.5 https://robertgish.com/blog/updated-management-of-hbv-in-pregnancy 2019-10-14 daily 0.5 https://robertgish.com/blog/sustained-virologic-response-to-direct-acting-antiviral-therapy 2019-10-11 daily 0.5 https://robertgish.com/blog/hepatic-fibrosis-as-the-strongest-predictor-of-liver-related-outcomes-and-mortality-among-nonalcoholic-steatohepatitis-nash 2019-09-30 daily 0.5 https://robertgish.com/blog/2019-hepatitis-b-guidance-update-on-prevention-diagnosis-and-treatment-of-chronic-hepatitis-b 2019-09-27 daily 0.5 https://robertgish.com/blog/hbv-and-hcc-hot-topics-2019 2019-09-25 daily 0.5 https://robertgish.com/blog/national-viral-hepatitis-progress-report-2019 2019-09-22 daily 0.5 https://robertgish.com/blog/immunotolerant-old-name-new-name-chronic-infection-hbv 2019-09-16 daily 0.5 https://robertgish.com/blog/taf-appeal-letter-2019 2019-08-05 daily 0.5 https://robertgish.com/blog/liraglutide-sitagliptin-and-insulin-glargine-added-to-metformin-in-patients-with-type-2-diabetes 2019-07-22 daily 0.5 https://robertgish.com/blog/imaging-and-biomarkers-in-hcc 2019-07-19 daily 0.5 https://robertgish.com/blog/my-hepatitis-b-viral-load-is-low 2019-07-18 daily 0.5 https://robertgish.com/blog/new-program-offers-affordable-hepatitis-b-treatments-in-the-us 2019-07-17 daily 0.5 https://robertgish.com/blog/world-hepatitis-day 2019-07-15 daily 0.5 https://robertgish.com/blog/hbv-hot-topics-2019 2019-07-05 daily 0.5 https://robertgish.com/blog/treatment-of-hepatitis-delta-with-pegifn-alfa 2019-07-03 daily 0.5 https://robertgish.com/blog/estimates-of-prevalence-of-hepatitis-delta-infection-hotspots-and-updates 2019-06-29 daily 0.5 https://robertgish.com/blog/guidance-update-on-prevention-diagnosis-and-treatment-of-chronic-hepatitis-b-2019 2019-06-27 daily 0.5 https://robertgish.com/blog/hepatitis-c-patient-summit 2019-05-15 daily 0.5 https://robertgish.com/blog/hepatitis-b-virus-immunization-in-adults 2019-05-10 daily 0.5 https://robertgish.com/blog/short-term-rna-interference-therapy-in-chronic-hepatitis-b 2019-05-08 daily 0.5 https://robertgish.com/blog/hcc-looking-for-a-cure 2019-05-06 daily 0.5 https://robertgish.com/blog/hot-topics-in-hbc-cure-2019 2019-05-04 daily 0.5 https://robertgish.com/blog/hbv-test-interpretation-recommend-who-to-screen-for-hbv 2019-05-02 daily 0.5 https://robertgish.com/blog/new-and-improved-pbc-foundation-self-management-app 2019-04-25 daily 0.5 https://robertgish.com/blog/hepatitis-delta-flying-under-the-radar-in-the-u-s 2019-04-22 daily 0.5 https://robertgish.com/blog/hep-dart-2019 2019-04-17 daily 0.5 https://robertgish.com/blog/2019-annual-cco-hepatitis-symposium 2019-04-09 daily 0.5 https://robertgish.com/blog/hepatitis-b-virus-immunization-in-adults 2019-04-08 daily 0.5 https://robertgish.com/blog/screening-for-liver-diseasethe-work-up-and-diagnosis-of-acute-and-chronic-liver-disease 2019-04-03 daily 0.5 https://robertgish.com/blog/hcc-innovations-chronic-liver-disease-foundation 2019-03-22 daily 0.5 https://robertgish.com/blog/solid-organ-transplant-workshop 2019-03-15 daily 0.5 https://robertgish.com/blog/where-can-i-order-hepatitis-d-testing 2019-03-08 daily 0.5 https://robertgish.com/blog/management-of-tace-refractory-hepatocellular-carcinoma 2019-03-07 daily 0.5 https://robertgish.com/blog/webinar-screening-for-liver-disease-the-work-up-and-diagnosis-of-acute-and-chronic-liver-disease 2019-02-23 daily 0.5 https://robertgish.com/blog/liver-transplantation-for-cholangiocarcinoma 2019-02-20 daily 0.5 https://robertgish.com/blog/improved-liver-transplant-waitlist-mortality-and-lower-risk-of-disease-progression 2019-02-20 daily 0.5 https://robertgish.com/blog/hepatitis-d-virus-rna-quantitative-real-time-pcr 2019-02-12 daily 0.5 https://robertgish.com/blog/34th-annual-new-treatments-in-chronic-liver-disease 2019-02-07 daily 0.5 https://robertgish.com/blog/2019-updates-on-esophageal-disease 2019-01-31 daily 0.5 https://robertgish.com/blog/stanford-symposium-on-inflammatory-bowel-disease-advances-in-research-and-practice 2019-01-25 daily 0.5 https://robertgish.com/blog/anti-hbc-state-of-the-art-what-is-the-core-of-the-issues 2018-12-22 daily 0.5 https://robertgish.com/blog/expanding-hepatitis-c-virus-care-and-cure-national-experience-using-a-clinical-pharmacist-driven-model 2018-12-22 daily 0.5 https://robertgish.com/blog/hcc-surveillance-in-an-era-of-biomarkers-application-of-state-of-the-art-tools 2018-12-21 daily 0.5 https://robertgish.com/blog/chronic-hepatitis-b-infection-with-high-hbv-dna-and-normal-alt-to-treat-or-not-to-treat 2018-12-19 daily 0.5 https://robertgish.com/blog/lysosomal-acid-lipase-deficiency-lal-d-prevalence-and-incidence-testing-program 2018-12-14 daily 0.5 https://robertgish.com/blog/ask-an-expert-managing-hepatitis-delta-during-pregnancy 2018-12-09 daily 0.5 https://robertgish.com/blog/apasl-stc-2019-delta-hepatitis 2018-11-21 daily 0.5 https://robertgish.com/blog/emerging-therapies-for-pbc-nash-and-esld-and-hcc-seminar-series-2018-2019 2018-11-13 daily 0.5 https://robertgish.com/blog/hepatitis-c-the-state-of-medicaid-access 2018-11-08 daily 0.5 https://robertgish.com/blog/hepatitis-delta-epidemiology-diagnosis-and-management-36-years-after-discovery 2018-10-24 daily 0.5 https://robertgish.com/blog/a-stunning-health-outreach 2018-10-15 daily 0.5 https://robertgish.com/blog/hepatitis-b-foundation-reception 2018-10-02 daily 0.5 https://robertgish.com/blog/stanford-symposium-on-hbv-and-hdv 2018-08-24 daily 0.5 https://robertgish.com/blog/cholestatic-and-autoimmune-liver-disease 2018-08-19 daily 0.5 https://robertgish.com/blog/hepatitis-b-foundation-calls-for-universal-screening-for-hepatitis-b 2018-07-24 daily 0.5 https://robertgish.com/blog/hbv-global-prime-education 2018-07-19 daily 0.5 https://robertgish.com/blog/advances-in-hbv-disease-management 2018-07-18 daily 0.5 https://robertgish.com/blog/quantitative-serum-hepatitis-b-surface-antigen-hbsag-assay-validation-for-u-s-patient-testing 2018-07-17 daily 0.5 https://robertgish.com/blog/best-practices-for-hbv-therapy-using-hbv-dna-quant 2018-07-13 daily 0.5 https://robertgish.com/blog/qhbsag-quantitative-hbv-surface-antigen 2018-07-13 daily 0.5 https://robertgish.com/blog/hepatitis-delta-molecular-virology-webinar 2018-06-26 daily 0.5 https://robertgish.com/blog/world-hepatitis-day-2018 2018-06-15 daily 0.5 https://robertgish.com/blog/barriers-and-challenges-and-steps-towards-hbv-and-hcv-elimination 2018-06-07 daily 0.5 https://robertgish.com/blog/charting-a-course-to-better-hepatitis-b-care-worldwide-global-perspectives-ce 2018-06-05 daily 0.5 https://robertgish.com/blog/hepatitis-b-at-a-glance-asian-american-and-pacific-islander-communities 2018-06-04 daily 0.5 https://robertgish.com/blog/hepatitis-b-at-a-glance-men-who-have-sex-with-men 2018-06-01 daily 0.5 https://robertgish.com/blog/nvhr-applauds-new-aasld-and-idsa-guidelines-for-hepatitis-c-screening 2018-05-28 daily 0.5 https://robertgish.com/blog/management-of-pbc 2018-05-23 daily 0.5 https://robertgish.com/blog/pcb-monitoring-template 2018-05-22 daily 0.5 https://robertgish.com/blog/easl-clinical-practice-guidelines 2018-05-22 daily 0.5 https://robertgish.com/blog/hepatitis-awareness-month 2018-05-14 daily 0.5 https://robertgish.com/blog/nash-fibroscan-overview 2018-04-30 daily 0.5 https://robertgish.com/blog/2018-annual-cco-hepatitis-symposium 2018-04-26 daily 0.5 https://robertgish.com/blog/hepatitis-delta-in-romania 2018-04-19 daily 0.5 https://robertgish.com/blog/rna-interference-therapy-with-arc-520-injection 2018-04-15 daily 0.5 https://robertgish.com/blog/global-hepatitis-summit-2018 2018-04-11 daily 0.5 https://robertgish.com/blog/2018-pbc-conference 2018-04-06 daily 0.5 https://robertgish.com/blog/hvc-treatment-access 2018-04-05 daily 0.5 https://robertgish.com/blog/2nd-annual-symposium-updates-on-esophageal-disease-2018 2018-04-02 daily 0.5 https://robertgish.com/blog/a-research-agenda-for-curing-chronic-hepatitis-b-virus-infection 2018-03-29 daily 0.5 https://robertgish.com/blog/a-key-target-for-new-hbv-therapies 2018-03-19 daily 0.5 https://robertgish.com/blog/improving-patient-outcome-with-early-detection-of-hcc 2018-03-08 daily 0.5 https://robertgish.com/blog/emmet-b-keeffe-symposium-insulin-resistance-and-nafld 2018-02-27 daily 0.5 https://robertgish.com/blog/2018-pbc-conference-may-17th-19th 2018-02-26 daily 0.5 https://robertgish.com/blog/two-dose-heplisav-b-adult-hbv-vaccine-recommended-by-cdc-acip 2018-02-25 daily 0.5 https://robertgish.com/blog/hcv-renal-disease-extrahepatic-manifestations-powerpoint 2018-02-25 daily 0.5 https://robertgish.com/blog/aixplorer-ultimate-ultrasound-diagnostic-systems 2018-02-16 daily 0.5 https://robertgish.com/blog/hbv-echo-reducing-perinatal-transmission 2018-01-23 daily 0.5 https://robertgish.com/blog/updated-brochures-hepatitis-b-nafld-and-alcoholic-hepatitis-multiple-languages 2018-01-16 daily 0.5 https://robertgish.com/blog/the-cochrane-review-conclusion-for-hepatitis-c-daa-therapies-is-wrong 2018-01-16 daily 0.5 https://robertgish.com/blog/Letter-to-President-Trump-America-Is-Falling-Behind-in-Hepatitis-Elimination-Efforts 2018-01-09 daily 0.5 https://robertgish.com/blog/Updated-Patient-Fact-Sheet-Hepatitis-B-and-Drug-Use 2018-01-08 daily 0.5 https://robertgish.com/blog/Research-priorities-for-the-discovery-of-a-cure-for-chronic-hepatitis-B 2017-12-26 daily 0.5 https://robertgish.com/blog/APASL-2018-Abstract-Submission-Deadline 2017-12-13 daily 0.5 https://robertgish.com/blog/NVHR-Webinar-Hepatitis-C-Among-Pregnant-Women 2017-12-07 daily 0.5 https://robertgish.com/blog/Anti-HBc-What-is-the-Core-of-the-Story 2017-12-05 daily 0.5 https://robertgish.com/blog/Addressing-the-Challenges-of-PBC 2017-11-27 daily 0.5 https://robertgish.com/blog/weight-loss-contract-helping-patients-achieve-a-healthy-weight 2017-11-22 daily 0.5 https://robertgish.com/blog/report-forging-a-path-to-hcv-elimination 2017-11-20 daily 0.5 https://robertgish.com/blog/New-2-dose-adult-HBV-vaccine-FDA-approved 2017-11-20 daily 0.5 https://robertgish.com/blog/video-monitoring-at-risk-patients-for-liver-cancer 2017-10-25 daily 0.5 https://robertgish.com/blog/Updated-Patient-Handout-Understanding-Hep-B-Test-Results-Core-Antibody 2017-10-10 daily 0.5 https://robertgish.com/blog/Hepatitis-B-Roadmap-For-a-Cure 2017-10-06 daily 0.5 https://robertgish.com/blog/HCV-Treatment-Quick-Guide-Updated-Oct-2017 2017-10-06 daily 0.5 https://robertgish.com/blog/Current-Management-of-Alcoholic-Hepatitis-August-2017 2017-08-31 daily 0.5 https://robertgish.com/blog/HCV-HBV-HCC-Perspectives-US-approach-using-global-data 2017-08-15 daily 0.5 https://robertgish.com/blog/Slidedeck-HBV-Treatment-Endpoints-and-Research-Directions-for-Functional-Cure 2017-08-02 daily 0.5 https://robertgish.com/blog/Drugs-in-Development-for-Hepatitis-B-June-2017 2017-08-02 daily 0.5 https://robertgish.com/blog/World-Hepatitis-Day-2017-CEVHAP-Activity-Update 2017-07-28 daily 0.5 https://robertgish.com/blog/The-current-and-evolving-role-of-Hepatitis-B-Virus-Core-antibody-anti-HBc-in-clinical-practice-Abstract 2017-07-27 daily 0.5 https://robertgish.com/blog/Management-of-Hepatic-Encephalopathy-A-focus-on-Rifaximin 2017-07-27 daily 0.5 https://robertgish.com/blog/Patient-Handout-Understanding-Hep-B-Test-Results-Core-Antibody 2017-07-21 daily 0.5 https://robertgish.com/blog/Which-Strategies-Have-Been-Proven-to-Reverse-Fibrosis-and-Cirrhosis-in-HBV-Patients 2017-07-20 daily 0.5 https://robertgish.com/blog/Tenofovir-alafenamide-for-the-treatment-of-chronic-hepatitis-B-virus-infection 2017-06-15 daily 0.5 https://robertgish.com/blog/Current-Management-of-Alcoholic-Hepatitis-Slidedeck-June-2017 2017-06-13 daily 0.5 https://robertgish.com/blog/Dangerous-Threat-HBVHDV-Coinfection 2017-06-07 daily 0.5 https://robertgish.com/blog/Coverage-Guide-for-Hepatitis-C-Testing-Rev-June-2017 2017-06-05 daily 0.5 https://robertgish.com/blog/Comprehensive-HCV-Testing-Screening-Guide-for-Providers 2017-05-19 daily 0.5 https://robertgish.com/blog/National-and-State-Level-HCV-Prevalence-and-Mortality-Maps-Launched 2017-04-28 daily 0.5 https://robertgish.com/blog/First-FDA-approved-treatment-for-a-liver-cancer-in-almost-a-decade 2017-04-28 daily 0.5 https://robertgish.com/blog/Quantitative-Hepatitis-B-Surface-Antigen-qHBsAg-Full-Webinar-Recording-with-Slides 2017-04-17 daily 0.5 https://robertgish.com/blog/Hepatitis-Delta-The-Hidden-Epidemic-Full-Webinar-Recording 2017-04-17 daily 0.5 https://robertgish.com/blog/A-National-Strategy-for-the-Elimination-of-Hepatitis-B-and-C-PHASE-2 2017-04-06 daily 0.5 https://robertgish.com/blog/Perinatal-HepB-Resources-for-Clinicians-and-Patients 2017-04-05 daily 0.5 https://robertgish.com/blog/PBC-Foundaton-UK-Winter-2017-Newsletter 2017-03-17 daily 0.5 https://robertgish.com/blog/Hep-A-Outbreak-Associated-with-Homelessness-Drug-Use-in-San-Diego-County 2017-03-11 daily 0.5 https://robertgish.com/blog/Potential-Applications-of-Serum-HBsAg-Level-Measurement-in-Patients-with-Hepatitis-B-and-D-CoInfection 2017-02-27 daily 0.5 https://robertgish.com/blog/According-to-Experts-HBsAg-is-an-essential-tool 2017-02-24 daily 0.5 https://robertgish.com/blog/WHO-Guidelines-on-HBV-and-HCV-Testing-Feb-2017 2017-02-23 daily 0.5 https://robertgish.com/blog/HHS-Webinar-382017-National-Viral-Hepatitis-Action-Plan 2017-02-23 daily 0.5 https://robertgish.com/blog/Settlement-Over-Hepatitis-Cure-OKd-Despite-Challenge-From-Attorneys-General 2017-02-19 daily 0.5 https://robertgish.com/blog/Comparisons-of-Hepatitis-C-Treatment-and-Costs-IMS-Institute-for-Healthcare-Informatics 2017-02-19 daily 0.5 https://robertgish.com/blog/HEP-DART-2017 2017-02-10 daily 0.5 https://robertgish.com/blog/Case-Study-Management-and-Treatment-of-Chronic-HCV-in-a-Patient-With-Genotype-3-Infection 2017-02-02 daily 0.5 https://robertgish.com/blog/National-Viral-Hepatitis-Action-Plan-2017-2020 2017-01-26 daily 0.5 https://robertgish.com/blog/Nominations-for-the-Distinguished-Award-in-Hepatitis-B-Research-are-still-open 2017-01-23 daily 0.5 https://robertgish.com/blog/Reactivation-of-Hepatitis-B-Virus-After-Treatment-with-Direct-Acting-Antivirals-for-Hepatitis-C-What-You-Need-To-Know 2017-01-21 daily 0.5 https://robertgish.com/blog/TAF-tenofovir-alafenamide-Professional-Opinion-Support-Letter 2017-01-20 daily 0.5 https://robertgish.com/blog/Quest-Diagnostics-Launches-Nations-First-Hepatitis-B-Virus-Quantitative-Test 2017-01-20 daily 0.5 https://robertgish.com/blog/Know-Hepatitis-B-Website-Updates-and-Facts-Sheet-in-New-Languages 2017-01-06 daily 0.5 https://robertgish.com/blog/HBV-monitoring-for-patients-on-HCV-DAA-Treatment-Chart 2016-12-09 daily 0.5 https://robertgish.com/blog/Treatment-Adherence-Patient-Handouts 2016-11-28 daily 0.5 https://robertgish.com/blog/Quantitative-Hepatitis-B-Surface-Antigen-HBsAg-Quest-Diagnostics 2016-11-23 daily 0.5 https://robertgish.com/blog/HBV-Reactivation-Webinar 2016-11-20 daily 0.5 https://robertgish.com/blog/HBV-Future-Therapies-and-Clinical-Trials-What-They-Mean-for-the-Hepatitis-B-Community-Free-Webinar 2016-11-20 daily 0.5 https://robertgish.com/blog/Future-Therapy-for-HBV-Role-of-Immunomodulators 2016-11-13 daily 0.5 https://robertgish.com/blog/Managing-Resistance-in-HCV-Infected-Patients-Treated-with-DAA-Regimens-Free-CME-Program 2016-11-02 daily 0.5 https://robertgish.com/blog/The-Increasing-Incidence-of-Liver-Cancer 2016-10-23 daily 0.5 https://robertgish.com/blog/Major-treatment-expansion-could-essentially-eliminate-hepatitis-C-in-RI-by-2030 2016-10-23 daily 0.5 https://robertgish.com/blog/Identifying-and-Managing-Patients-at-Risk-for-HBV-Reactivation-CME 2016-10-23 daily 0.5 https://robertgish.com/blog/Letter-of-Medical-Necessity-for-AFP-L3-and-DCP 2016-10-22 daily 0.5 https://robertgish.com/blog/Identifying-and-Managing-Patients-at-Risk-for-HBV-Reactivation-Free-CME-Program 2016-10-22 daily 0.5 https://robertgish.com/blog/High-out-of-pocket-costs-are-critical-barriers-to-care-and-treatment 2016-10-22 daily 0.5 https://robertgish.com/blog/Direct-acting-antivirals-for-the-treatment-of-chronic-hepatitis-C-in-patients-with-chronic-kidney-disease 2016-10-22 daily 0.5 https://robertgish.com/blog/Hepa-Info-in-Your-Inbox 2016-10-19 daily 0.5 https://robertgish.com/blog/Consumers-Insenced-Over-Health-Insurance-Premiums-and-Drug-Prices 2016-10-18 daily 0.5 https://robertgish.com/blog/APHF-Board-Meeting 2016-10-18 daily 0.5 https://robertgish.com/blog/Is-Well-Intended-Fed-Standard-Getting-Medicare-Patients-Dropped-from-Transplant-List 2016-10-16 daily 0.5 https://robertgish.com/blog/Webinar-October-18th-How-Hepatologists-and-Primary-Care-Practitioners-are-Key-to-the-Elimination-of-Viral-Hepatitis 2016-10-13 daily 0.5 https://robertgish.com/blog/Hepatitis-C-Virus-Identifying-and-Managing-Resistance-Associated-Variants 2016-10-06 daily 0.5 https://robertgish.com/blog/Use-of-Alpha-Fetoprotien-and-Other-Biomarkers-for-Assessing-HCC-Risk-in-Viral-Hepatitis 2016-09-30 daily 0.5 https://robertgish.com/blog/CMS-Approves-HBV-Screening-in-Primary-Care-Settings 2016-09-29 daily 0.5 https://robertgish.com/blog/Preventing-Reactivation-of-Hepatitis-B-Educational-Video 2016-09-23 daily 0.5 https://robertgish.com/blog/Patient-Survey-Psychological-Impact-of-HCV-and-HCVHIV-Co-Infection 2016-09-16 daily 0.5 https://robertgish.com/blog/NVHR-Webinar-Hepatitis-C-Screening-in-Emergency-Departments 2016-09-13 daily 0.5 https://robertgish.com/blog/1-Page-HCV-Treatment-Quick-Guide 2016-09-13 daily 0.5 https://robertgish.com/blog/PBC-Awareness-MonthDay 2016-09-08 daily 0.5 https://robertgish.com/blog/Sign-On-Letter-Ask-Secretary-Clinton-to-Raise-Profile-of-Viral-Hep-as-Urgent-Public-Health-Priority 2016-09-06 daily 0.5 https://robertgish.com/blog/Children-Exposed-To-Hepatitis-C-May-Be-Missing-Out-On-Treatment 2016-08-26 daily 0.5 https://robertgish.com/blog/NVHR-Webinar-Hepatitis-C-Treatment-Access 2016-08-25 daily 0.5 https://robertgish.com/blog/AASLD-Foundation-Announces-Autoimmune-Liver-Diseases-Pilot-Research-Award 2016-08-25 daily 0.5 https://robertgish.com/blog/Preventing-Hospital-Readimssions-in-Patients-With-Cirrhosis-SOTA-2016 2016-08-23 daily 0.5 https://robertgish.com/blog/5th-Annual-Current-Trends-in-Liver-Disease-Phoenix-AZ-October-7th-Topic-Fatty-Liver-Disease 2016-08-11 daily 0.5 https://robertgish.com/blog/Did-You-Know-Fed-Law-requires-patientsguardians-to-receive-Vaccination-Information-Statements-before-every-dose 2016-08-07 daily 0.5 https://robertgish.com/blog/Identification-of-HCV-infection-among-women-of-childbearing-age-and-infants-exist-but-requires-widespread-implementation 2016-08-06 daily 0.5 https://robertgish.com/blog/Natl-Coalition-Combats-Hepatitis-B 2016-08-05 daily 0.5 https://robertgish.com/blog/Hepatocellular-Carcinoma-Podcast-by-Robert-Gish-MD 2016-08-04 daily 0.5 https://robertgish.com/blog/Post-WHD-2016-Model-for-Action-SF-PublicPrivateNGO-Collaboration 2016-08-03 daily 0.5 https://robertgish.com/blog/Closing-a-Healthcare-Gap-Medicare-Finally-Covers-Hepatitis-B-Testing-in-At-risk-Seniors 2016-07-26 daily 0.5 https://robertgish.com/blog/Hepatitis-C-in-California-The-Role-of-the-Primary-Care-Team-FREE-CME-WEBINAR-Friday-July-22-1200-130-pm 2016-07-20 daily 0.5 https://robertgish.com/blog/CMS-Proposed-Decision-Memo-for-Screening-for-HBV-Infection 2016-07-20 daily 0.5 https://robertgish.com/blog/Sign-up-to-be-an-Organ-Donor-Theres-an-App-for-that 2016-07-09 daily 0.5 https://robertgish.com/blog/PBC-Updates-from-San-Diego-and-Barcelona-Medscape-Gastroenterology-CME-Activity 2016-07-09 daily 0.5 https://robertgish.com/blog/Lysosomal-Acid-Lipase-Deficiency-LAL-D-an-under-recognized-inherited-disease-affecting-both-children-and-adults 2016-07-09 daily 0.5 https://robertgish.com/blog/Hepatitis-B-Virus-Infection-HBV-in-2016-in-the-US 2016-07-01 daily 0.5 https://robertgish.com/blog/Alcoholic-Liver-Disease-High-Risk-or-Low-Risk-for-Developing-HCC 2016-07-01 daily 0.5 https://robertgish.com/blog/WHO-Guidelines-for-the-Prevention-Care-and-Treatment-of-Persons-With-Chronic-Hepatitis-B-Infection 2016-06-25 daily 0.5 https://robertgish.com/blog/HCC-Era-of-Biomarkers-Application-of-State-of-the-Art-Tools 2016-06-17 daily 0.5 https://robertgish.com/blog/PBC-and-PSC-Easy-to-Understand-Videos-for-Med-Students-Advocates-and-Patients 2016-06-15 daily 0.5 https://robertgish.com/blog/PBC-NASHNAFLD-Chronic-B-C-and-HCC 2016-06-15 daily 0.5 https://robertgish.com/blog/Improving-Access-to-Hepatitis-Cures 2016-06-15 daily 0.5 https://robertgish.com/blog/Hep-B-United-Summit-July-27-29-2016-Washington-DC 2016-06-15 daily 0.5 https://robertgish.com/blog/Clinical-Trial-Watch-Liver-Meeting-AASLD-Nov-2015 2016-06-15 daily 0.5 https://robertgish.com/blog/The-Pan-Genotypic-Era-of-HCV-Care-Lectures 2016-06-14 daily 0.5 https://robertgish.com/blog/The-Complete-Guide-to-Communication-Skills-in-Clinical-Practice 2016-06-14 daily 0.5 https://robertgish.com/blog/Strategic-Plan-thru-2020-Natl-Center-for-HIVAIDS-Viral-Hep-STD-TB-Prevention 2016-06-14 daily 0.5 https://robertgish.com/blog/NVHR-Launches-HCV-Tx-Access-Resource-Page 2016-06-14 daily 0.5 https://robertgish.com/blog/NCI-Offers-Toll-Free-Cancer-Information-and-Support-at-1-800-4-CANCER 2016-06-14 daily 0.5 https://robertgish.com/blog/FDA-approves-Ocaliva-for-PBC 2016-06-14 daily 0.5 https://robertgish.com/blog/Cancer-Caregivers-Facing-the-Challenge-Together 2016-06-14 daily 0.5 https://robertgish.com/blog/The-Increasing-Incidence-of-Liver-Cancer 2016-06-11 daily 0.5 https://robertgish.com/blog/Cancer-Incidence-Articles 2016-06-11 daily 0.5 https://robertgish.com/blog/WHO-Prices-Costs-and-Affordability-of-New-Meds-for-HCV-in-30-Countries-An-Economic-Analysis 2016-06-10 daily 0.5 https://robertgish.com/blog/The-International-Liver-Transplant-Society-Guideline-on-Living-Liver-Donation 2016-06-10 daily 0.5 https://robertgish.com/blog/Register-June-17th-Webinar-on-State-Level-HCV-Treatment-Access-Successes 2016-06-10 daily 0.5 https://robertgish.com/blog/A-Revolution-in-Treatment-for-Hepatitis-C-Infection-Mitigating-the-Budgetary-Impact 2016-06-10 daily 0.5 https://robertgish.com/blog/QI-Methods-for-Complex-Adaptive-Systems-Applied-to-an-Academic-Hepatology-Program 2016-06-09 daily 0.5 https://robertgish.com/blog/Project-ECHO-trains-and-supports-primary-care-physicians-to-treat-HCV-locally-rather-than-refer-to-distant-specialists-Learn-more 2016-06-09 daily 0.5 https://robertgish.com/blog/Minimum-Costs-to-Treat-Viral-Hep-Extremely-high-prices-is-restricting-patient-access 2016-06-09 daily 0.5 https://robertgish.com/blog/Focus-on-Therapy-of-Hepatitis-B-Planning-for-2015-and-beyond 2016-06-09 daily 0.5 https://robertgish.com/blog/Seeking-Liver-Transplant-Hepatologist-for-newly-establishedrapidly-growing-liver-program-Phoenix-AZ 2016-06-07 daily 0.5 https://robertgish.com/blog/Progress-Florida-changes-Medicaid-hep-C-drug-policy 2016-06-07 daily 0.5 https://robertgish.com/blog/Best-of-the-Liver-Summit-PBC-NAFLDNASH-and-HCV 2016-06-06 daily 0.5 https://robertgish.com/blog/Best-of-HCV-2016-Spring-Update-Expert-Perspectives-IC-HEP-Webcast 2016-06-06 daily 0.5 https://robertgish.com/blog/2016-Stanford-Solid-Organ-Transplant-Symposium-June-24-2016 2016-06-06 daily 0.5 https://robertgish.com/blog/WHO-Global-Viral-Hepatitis-Strategy-ADOPTED 2016-05-31 daily 0.5 https://robertgish.com/blog/Federal-Court-Requires-WA-Medicaid-to-Provide-HCV-Cure-to-Patients 2016-05-29 daily 0.5 https://robertgish.com/blog/Register-Now-National-Strategy-on-the-Elimination-of-Hep-B-C-Meeting-3 2016-05-25 daily 0.5 https://robertgish.com/blog/Patient-Handout-Understanding-Hep-B-Test-Results 2016-05-24 daily 0.5 https://robertgish.com/blog/PBC-Conference-Houston-TX-Registration-Ends-Soon 2016-05-24 daily 0.5 https://robertgish.com/blog/No-More-Excuses-Viral-Hepatitis-Can-Be-Eliminated 2016-05-24 daily 0.5 https://robertgish.com/blog/AASLD-Launches-Public-Health-Health-Care-Delivery-Special-Interest-Group 2016-05-24 daily 0.5 https://robertgish.com/blog/MA-advocates-call-for-removal-of-unreasonable-restrictions-for-HCV-treatment 2016-05-20 daily 0.5 https://robertgish.com/blog/Low-SVR-Rates-in-GT2-and-GT3-Patients-with-Quantifiable-Hepatitis-C-Virus-at-Week-4-of-SOF-Treatment 2016-05-20 daily 0.5 https://robertgish.com/blog/LabCorp-offers-HCV-Genotyping-with-1a-Subtype-Reflex-to-HCV-NS5A-Drug-Resistance-Assay 2016-05-20 daily 0.5 https://robertgish.com/blog/IfPA-Access-to-Hepatitis-C-Cures-for-Medicaid-Patients 2016-05-20 daily 0.5 https://robertgish.com/blog/HCV-Treatment-Access-Restrictions-Coverage-Obligations-under-the-Law 2016-05-20 daily 0.5 https://robertgish.com/blog/HCV-Resistance-Where-are-we-and-where-are-we-going 2016-05-20 daily 0.5 https://robertgish.com/blog/Forget-Surface-Antibodies-If-You-Have-Undetectable-HBV-Viral-Load-and-HBsAg-You-Just-Might-Be-Functionally-Cured 2016-05-20 daily 0.5 https://robertgish.com/blog/BMJ-Predictors-of-hepatic-decomp-after-TACE-for-HCC 2016-05-20 daily 0.5 https://robertgish.com/blog/A-Name-Change-for-PBC-Cholangitis-Replacing-Cirrhosis 2016-05-20 daily 0.5 https://robertgish.com/blog/Interpretation-of-HBV-Serology-Fact-Sheet 2016-05-17 daily 0.5 https://robertgish.com/blog/Chronic-hepatitis-B-in-the-Philippines 2016-05-17 daily 0.5 https://robertgish.com/blog/Abnormal-Liver-Tests-Workup-and-Diagnosis-2016 2016-05-17 daily 0.5 https://robertgish.com/blog/Updated-Recommendations-for-Testing-Managing-and-Treating-Hepatitis-C 2016-05-16 daily 0.5 https://robertgish.com/blog/Sample-Letters-Responding-to-State-Medicaid-Restrictions 2016-05-16 daily 0.5 https://robertgish.com/blog/Roadmap-for-HBV-eradication-Barriers-and-Catalysts-for-HBV-Education-Testing-and-Linkage-to-Care 2016-05-16 daily 0.5 https://robertgish.com/blog/Quest-Diagnostics-to-Automatically-Confirm-HCVab-with-NAT 2016-05-16 daily 0.5 https://robertgish.com/blog/NVHR-Summary-of-Panel-on-CommunityProvider-Partnerships-at-AASLD 2016-05-16 daily 0.5 https://robertgish.com/blog/Forum-for-Collaborative-HIV-Research-3rd-Liver-Forum-Meeting-11122015 2016-05-16 daily 0.5 https://robertgish.com/blog/FDA-approved-fixed-dose-combination-elbasvir-grazoprevir-Zepatier-for-treatment-of-chronic-hepatitis-C-genotypes-1-or-4 2016-05-16 daily 0.5 https://robertgish.com/blog/Current-Data-and-Expert-Insights-from-the-2016-Gastrointestinal-Cancers-Meeting 2016-05-16 daily 0.5 https://robertgish.com/blog/Centers-for-Medicare-and-Medicaid-Services-CMS-National-Coverage-Analysis-for-hepatitis-B-screening-for-Medicare-beneficiaries 2016-05-16 daily 0.5 https://robertgish.com/blog/CEVHAP-Closing-the-Gap-Report-20142015 2016-05-16 daily 0.5 https://robertgish.com/blog/New-Case-Reporting-Requirements-for-Acute-HCV-Effective-112016 2016-05-16 daily 0.5 https://robertgish.com/blog/State-Medicaid-Restrictions-for-Hepatitis-C-Cures-Are-Creating-One-of-America-s-Worst-Health-Disparities 2016-05-15 daily 0.5 https://robertgish.com/blog/Hepatitis-C-Virus-as-a-Systemic-Disease-Reaching-Beyond-the-Liver 2016-05-15 daily 0.5 https://robertgish.com/blog/FY-2016-Funding-Bill-Falls-Short-in-Fight-Against-Hepatitis-B-and-C 2016-05-15 daily 0.5 https://robertgish.com/blog/WSU-College-of-Pharmacy-looks-at-impact-of-pharmacist-provided-HCV-screening 2016-05-14 daily 0.5 https://robertgish.com/blog/Pharma-Co-What 2016-05-14 daily 0.5 https://robertgish.com/blog/HCV-Treatment-and-the-Veterans-Choice-Program 2016-05-14 daily 0.5 https://robertgish.com/blog/From-the-Floor-to-the-ICU-to-You 2016-05-14 daily 0.5 https://robertgish.com/blog/Eliminating-the-Public-Health-Problem-of-Hepatitis-B-and-C-in-the-US 2016-05-14 daily 0.5 https://robertgish.com/blog/Dr-Gish-Urges-Asian-Americans-to-Test-for-Hepatitis-B 2016-05-14 daily 0.5 https://robertgish.com/blog/Cirrhosis-and-Coagulation 2016-05-14 daily 0.5 https://robertgish.com/blog/Care-of-the-LIVER-Patient-in-the-Hospital-When-to-Transfer 2016-05-14 daily 0.5 https://robertgish.com/blog/Article-in-The-Journal-of-Medical-Practice-Management 2015-10-04 daily 0.5 https://robertgish.com/blog/Conference-Focus-on-the-Hepatitis-B-Virus 2015-10-02 daily 0.5 https://robertgish.com/blog/Article-Hepatology-Prevalence-of-Chronic-HBV-and-HCV 2015-10-02 daily 0.5 https://robertgish.com/blog/HCV-Policy-Presentation-2015 2015-09-08 daily 0.5 https://robertgish.com/blog/Abnormal-Liver-Tests-Presentation 2015-09-04 daily 0.5 https://robertgish.com/blog/Outreach-at-Our-Lady-of-Sacred-Heart-on-August-16-2015 2015-08-19 daily 0.5 https://robertgish.com/blog/Health-Screenings-at-Sovannkiry-Temple 2015-08-09 daily 0.5 https://robertgish.com/blog/Voices-Dr-Robert-Gish-Hepatitis-B-and-C-are-the-leading-causes-of-liver-cancer 2015-07-14 daily 0.5 https://robertgish.com/blog/HCC-Surveillance-in-an-Era-of-Biomarkers 2015-06-07 daily 0.5 https://robertgish.com/blog/Article-in-Hepatology-International-042015 2015-05-25 daily 0.5 https://robertgish.com/blog/Now-Available-to-View-Listen-Webinar-Treatment-Options-for-Liver-Cancer 2015-05-12 daily 0.5 https://robertgish.com/blog/Dr-Robert-Gish-Receives-Award 2015-04-17 daily 0.5 https://robertgish.com/blog/Free-Webinar-Treatment-Options-for-Liver-Cancer-What-You-Need-To-Know 2015-04-07 daily 0.5 https://robertgish.com/blog/Message-to-AASLD-Members-Help-Us-Grow-the-Fellows-Program 2015-04-04 daily 0.5 https://robertgish.com/blog/Prevention-and-Control-of-Hepatitis-B-and-Hepatitis-C-in-the-Philippines 2015-04-02 daily 0.5 https://robertgish.com/blog/Increasing-Knowledge-of-Molecular-Pathways-In-Hepatocellular-Carcinoma 2015-03-24 daily 0.5 https://robertgish.com/blog/Efficacy-of-Combination-Treatment-Modalities-for-Intermediate-and-Advanced-Hepatocellular-Carcinoma 2015-03-24 daily 0.5 https://robertgish.com/blog/Liver-Biopsy-versus-NonInvasive-Tests-of-Fibrosis 2015-03-19 daily 0.5 https://robertgish.com/blog/Dr-Eugene-Schiff-Receives-an-Award 2015-03-04 daily 0.5 https://robertgish.com/blog/Walking-Across-America-for-Wilsons-Disease 2015-03-03 daily 0.5 https://robertgish.com/blog/Autoimmune-Hepatitis 2015-03-03 daily 0.5 https://robertgish.com/blog/Common-Questions-and-Answers-for-Patients-with-or-At-Risk-for-Cirrhosis 2015-02-26 daily 0.5 https://robertgish.com/blog/Increasing-Knowledge-of-Molecular-Pathways-In-Hepatocellular-Carcinoma 2015-02-24 daily 0.5 https://robertgish.com/blog/Project-ECHO-Hepatitis-C-Clinical-Guidelines 2015-02-17 daily 0.5 https://robertgish.com/blog/HCC-Screening 2015-02-08 daily 0.5 https://robertgish.com/blog/Stanford-Liver-Transplant-and-General-Hepatology-Outreach-San-Francisco 2015-02-04 daily 0.5 https://robertgish.com/blog/Stanford-Liver-Transplant-and-General-Hepatology-Outreach-Henderson 2015-02-04 daily 0.5 https://robertgish.com/blog/Stanford-Liver-Transplant-and-General-Hepatology-Outreach-Fresno 2015-02-04 daily 0.5 https://robertgish.com/blog/DRAFT-2016-Letter-to-Issuers-in-the-Federallyfacilitated-Marketplaces 2015-02-04 daily 0.5 https://robertgish.com/blog/Tet-Celebration-on-Saturday-Jan-24-2015 2015-01-26 daily 0.5 https://robertgish.com/blog/Liver-Cancer-Fact-Sheet 2015-01-26 daily 0.5 https://robertgish.com/blog/Herbal-Medications-and-Liver-Toxicity 2015-01-26 daily 0.5 https://robertgish.com/blog/weight-loss-contract 2015-01-25 daily 0.5 https://robertgish.com/blog/Robert-G-Gish-MD-Full-Curriculum-Vitae-Biography-Updated-January-2015 2015-01-25 daily 0.5 https://robertgish.com/blog/Newest-treatments-for-Hepatitis-C-Genotype-1 2015-01-25 daily 0.5 https://robertgish.com/blog/Liver-and-Liver-Transplant-Program-Nutrition-Guidelines 2015-01-25 daily 0.5 https://robertgish.com/blog/Letter-To-The-Chronicle 2015-01-25 daily 0.5 https://robertgish.com/blog/High-Rate-of-Core-Promoter-and-Precore-Mutations-In-Patients-With-Chronic-Hepatitis-B 2015-01-25 daily 0.5 https://robertgish.com/blog/Frequently-Asked-Questions-About-Hepatitis-C 2015-01-25 daily 0.5 https://robertgish.com/blog/Covalently-ClosedCircular-Hepatitis-B-Virus-DNA-Reduction-With-Entecavir-and-Lamivudine 2015-01-25 daily 0.5 https://robertgish.com/blog/Centers-for-Medicare-and-Medicaid-Services-CMS-Covers-Hepatitis-C-Screening 2015-01-25 daily 0.5 https://robertgish.com/blog/An-Evaluation-on-the-Mortality-of-Adult-Liver-Transplantation-WaitList-Registrants-in-the-United-States 2015-01-25 daily 0.5 https://robertgish.com/blog/New-NVHR-Resources-Treatment-Access-StateSpecific-HCV-Data 2015-01-23 daily 0.5 https://robertgish.com/blog/AASLD-2014-HBV-Post-Conference-Update-112114 2014-11-21 daily 0.5 https://robertgish.com/blog/PBCers-release-statement-on-Name-Change-Initiative 2014-11-21 daily 0.5 https://robertgish.com/blog/Solvadi-Letter-to-Congress-Natl-Assn-of-Medicaid-Directors 2014-10-28 daily 0.5 https://robertgish.com/blog/Ledipasvir-Sofosbuvir-Harvoni-10-26-2014-Update 2014-10-26 daily 0.5 https://robertgish.com/blog/Medicare-Learning-Network-releases-update-on-hepatitis-C-testing-benefit 2014-10-14 daily 0.5 https://robertgish.com/blog/Long-term-NUC-HBV-HCC-Prevention-and-Surveillance 2014-10-14 daily 0.5 https://robertgish.com/blog/Ascites-Hyponatremia-and-Spontaneous-Bacterial-Peritonitis-SOTA-2014-1 2014-10-14 daily 0.5 https://robertgish.com/blog/Hepatitis-D-Information-for-Health-Professionals 2014-10-07 daily 0.5 https://robertgish.com/blog/Seeking-subjects-for-alcoholic-liver-disease-study 2014-10-06 daily 0.5 https://robertgish.com/blog/New-York-State-Drug-Utilization-Review-Board-Hepatitis-C-Virus-Clinical-Criteria-Review 2014-10-06 daily 0.5 https://robertgish.com/blog/LIRADS-2014-comprehensive-imaging-diagnosis-system-for-HCC 2014-10-06 daily 0.5 https://robertgish.com/blog/Role-of-the-multidisciplinary-team-in-the-diagnosis-and-treatment-of-hepatocellular-carcinoma-1 2014-09-30 daily 0.5 https://robertgish.com/blog/Preventing-Hospital-Readmissions-for-Advanced-Liver-Disease 2014-09-22 daily 0.5 https://robertgish.com/blog/Primary-Biliary-Cirrhosis-Time-to-Replace-a-Misnomer 2014-09-17 daily 0.5 https://robertgish.com/blog/Autoimmune-Liver-Disease-Diagnosis-Sentences-Patients-to-Stigma 2014-09-17 daily 0.5 https://robertgish.com/blog/Live-CME-Meetings-Current-Perspectives-into-the-Management-of-Hepatic-Encephalopathy 2014-09-13 daily 0.5 https://robertgish.com/blog/Robert-Gish-MD-Awarded-FAASLD-Inaugural-Class-of-AASLD-Fellows 2014-09-10 daily 0.5 https://robertgish.com/blog/Community-Leaders-Call-For-End-To-Hepatitis-C-Treatment-Access-Crisis 2014-09-10 daily 0.5 https://robertgish.com/blog/Yellow-Warriors-Society-Philippines-Petitions-to-Prohibit-PreEmployment-Screening 2014-09-05 daily 0.5 https://robertgish.com/blog/Hepatitis-Bs-Impact-on-One-Filipino-Family 2014-09-05 daily 0.5 https://robertgish.com/blog/3rd-Annual-Current-Trends-in-Liver-Disease-Symposium-and-Gastroenterology-Board-Review-1 2014-09-01 daily 0.5 https://robertgish.com/blog/Next-Public-Meeting-of-CTAF-to-Examine-Newest-Treatments-for-Hepatitis-C 2014-08-24 daily 0.5 https://robertgish.com/blog/Letter-of-Medical-Necessity-for-AFPL3-and-DCP 2014-08-23 daily 0.5 https://robertgish.com/blog/Biomarkers-for-Risk-Assessment-of-Hepatocellular-Carcinoma 2014-08-23 daily 0.5 https://robertgish.com/blog/Expanding-Hep-B-Screening-Amoung-Asian-Populations-in-San-Diego-County 2014-08-21 daily 0.5 https://robertgish.com/blog/3rd-Annual-Current-Trends-in-Liver-Disease 2014-08-18 daily 0.5 https://robertgish.com/blog/Critical-Issues-in-HBV 2014-08-15 daily 0.5 https://robertgish.com/blog/Who-Gets-First-Dibs-on-Transplanted-Livers-Rules-May-Change 2014-08-14 daily 0.5 https://robertgish.com/blog/Lake-Erie-Toxic-Algae-and-Liver-Damage 2014-08-14 daily 0.5 https://robertgish.com/blog/Effects-of-Statins-on-the-Risk-of-Hepatocellular-Carcinoma 2014-08-12 daily 0.5 https://robertgish.com/blog/HCV-Treatment-Access-Letter-SignOn 2014-08-10 daily 0.5 https://robertgish.com/blog/Treatment-of-Chronic-HCV-Genotype-5-6 2014-08-03 daily 0.5 https://robertgish.com/blog/Treatment-of-Chronic-HCV-Genotype-4 2014-08-03 daily 0.5 https://robertgish.com/blog/abnormal-liver-tests-work-up-and-diagnosis-updated-2019 2014-07-30 daily 0.5 https://robertgish.com/blog/Weight-Management-Contract 2014-07-29 daily 0.5 https://robertgish.com/blog/Patient-Education-Sheets 2014-07-29 daily 0.5 https://robertgish.com/blog/The-Business-of-Liver-Transplantation 2014-07-25 daily 0.5 https://robertgish.com/blog/Dr-Gishs-Publication-Activity-2013-mid2014 2014-07-23 daily 0.5 https://robertgish.com/blog/Dr-Gish-Updated-CV-July-2014 2014-07-23 daily 0.5 https://robertgish.com/blog/Hepatopulmonary-Syndrome-Markedly-Increases-Mortality-in-Cirrhotic-Patients 2014-07-21 daily 0.5 https://robertgish.com/blog/Potential-of-a-Hec1-Inhibitor-as-Treatment-for-Primary-Liver-Cancer 2014-07-11 daily 0.5 https://robertgish.com/blog/Second-Annual-Hepatitis-C-Drug-Guide 2014-07-10 daily 0.5 https://robertgish.com/blog/A-Discussion-on-HCV-What-You-Need-To-Know 2014-07-10 daily 0.5 https://robertgish.com/blog/2014-National-Hepatitis-B-C-Training-Program-and-Treatment-Update 2014-07-05 daily 0.5 https://robertgish.com/blog/Liver-Transplant-Hepatologist-Opportunity-in-Phoenix-AZ 2014-07-01 daily 0.5 https://robertgish.com/blog/An-Invitation-to-Healthcare-Providers-to-Break-the-Silence-Around-Viral-Hepatitis 2014-06-30 daily 0.5 https://robertgish.com/blog/HCV-Treat-Now 2014-06-25 daily 0.5 https://robertgish.com/blog/Immunosuppression-in-Patients-with-Chronic-Hepatitis-B 2014-06-21 daily 0.5 https://robertgish.com/blog/VHAP-At-A-Glance-Viral-Hepatitis-Action-Plan-Updated-2014-2016 2014-06-19 daily 0.5 https://robertgish.com/blog/Redesigning-Liver-Distribution-to-Reduce-Variation-in-Access-to-Liver-Transplantation 2014-06-16 daily 0.5 https://robertgish.com/blog/medicare-to-cover-hcv-screening 2014-06-02 daily 0.5 https://robertgish.com/blog/Medicare-to-Cover-HCV-Screening 2014-06-02 daily 0.5